Totient

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

TenSixty Bio

The company develops an artificial intelligence platform to discover tumor-selective epitopes and create antibody-based therapeutics for healthcare providers and oncology patients.

Antiverse

This company uses generative AI to design functional antibody biologics for pharmaceutical organisations targeting complex medical conditions and transmembrane proteins.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

Aureka Biotechnologies

The company develops artificial intelligence platforms and antibody therapeutics for pharmaceutical and biotechnology organisations to accelerate the discovery and design of medicines.

Metaphore Biotechnologies

This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.

Computational drug discovery platform

This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.

Synteny

This company develops AI-based bioinformatic solutions and programmable protein therapeutics to help pharmaceutical and biotechnology firms discover treatments for immune-driven diseases.